POLPHARMA

We are the largest Polish manufacturer of pharmaceuticals and leader of the Polish pharmaceutical market. Actively we operate on the markets of Central and Eastern Europe, the Caucasus and Central Asia.
For 80 years we have the trust of patients, doctors and business partners.

We are among the 20 largest generics companies in the world, with a turnover of approx. 1 billion dollars a year. We employ more than 7,000 people in Poland and in foreign markets. We have 7 production plants in Poland, Russia and Kazakhstan, and 6 centers of research and development. Polpharma Group’s portfolio includes about 600 products, and another 200 are under development.

We produce prescription medicines and used in inpatient care. We have a leading share in key therapeutic areas in Poland. We specialize in cardiology, gastroenterology and neurology. A significant part of the product portfolio are the medications available over the counter (OTC). Our offer also includes dietary supplements, medical devices, cosmetics and fitofarmaceutyki. We are developing in the field of biological drugs – biosimilar and bioulepszonych. We are also the largest Polish manufacturer of pharmaceuticals that compete successfully in highly developed markets of the European Union and the United States.

We deliver the highest quality medicines and reliable medical knowledge. We are in the forefront of the most innovative companies in Poland in the rankings of the Institute of Economic Sciences. We are committed to the development of science and education and preventive health care.

WEB SITE